Publicaciones en colaboración con investigadores/as de Duke University (31)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

2022

  1. COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study

    Cancer Cytopathology, Vol. 130, Núm. 5, pp. 344-351

  2. Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity

    Developmental Cell, Vol. 57, Núm. 3, pp. 310-328.e9

  3. Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial

    World Journal of Urology, Vol. 40, Núm. 4, pp. 999-1004

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

    Blood, Vol. 137, Núm. 9, pp. 1154-1165

2020

  1. Congenital Uterine Malformation by Experts (CUME): diagnostic criteria for T-shaped uterus

    Ultrasound in Obstetrics and Gynecology, Vol. 55, Núm. 6, pp. 815-829

  2. Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries

    Cancer Cytopathology, Vol. 128, Núm. 12, pp. 885-894

  3. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

2019

  1. B cell-adaptive immune profile in emphysema-predominant chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine

2018

  1. Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus?

    Ultrasound in Obstetrics and Gynecology, Vol. 51, Núm. 1, pp. 101-109

2016

  1. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry

    Journal of the American Heart Association, Vol. 5, Núm. 10

  2. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 31-39

  3. Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma

    Clinical Cancer Research

  4. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557

2015

  1. Intraoperative Irradiation

    Clinical Radiation Oncology (Elsevier Inc.), pp. 325-340.e3

  2. Recurrent venous thromboembolism in anticoagulated patients with cancer: Management and short-term prognosis

    Journal of Thrombosis and Haemostasis, Vol. 13, Núm. 6, pp. 1010-1018

2013

  1. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration

    Nature Chemical Biology, Vol. 9, Núm. 9, pp. 586-594

2011

  1. Conclusions and Future Possibilities: IORT

    INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION

  2. IORT with Electron-Beam, High-Dose-Rate Brachytherapy or Low-KV/Electronic Brachytherapy: Methodological Comparisons

    INTRAOPERATIVE IRRADIATION: TECHNIQUES AND RESULTS, SECOND EDITION (HUMANA PRESS INC), pp. 99-115